相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors
Xiao Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014)
Xiao Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Recent Advances in the Discovery and Development of Novel HIV-1 NNRTI Platforms (Part II): 2009-2013 Update#
Yu’ning Song et al.
CURRENT MEDICINAL CHEMISTRY (2013)
HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
Peng Zhan et al.
MEDICINAL RESEARCH REVIEWS (2013)
Arylazolyl(azinyl)thioacetanilides. Part 10: Design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors
Xiao Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Synthesis, Biological Activity, and ADME Properties of Novel S-DABOs/N-DABOs as HIV Reverse Transcriptase Inhibitors
Marco Radi et al.
CHEMMEDCHEM (2012)
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
Jing Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Click Chemistry: 1,2,3-Triazoles as Pharmacophores
Sandip G. Agalave et al.
CHEMISTRY-AN ASIAN JOURNAL (2011)
Synthesis and Biological Evaluation of 6-Substituted 5-Alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as Potent HIV-1 NNRTIs
Mingyan Yu et al.
CHEMMEDCHEM (2011)
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005-2010)
Peng Zhan et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonylmethylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs
Mingyan Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies
Peng Zhan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Recent Advances in the Discovery and Development of Novel HIV-1 NNRTI Platforms: 2006-2008 Update
Peng Zhan et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Design Strategies of Novel NNRTIs to Overcome Drug Resistance
Peng Zhan et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Discovery of Chiral Cyclopropyl Dihydro-Alkylthio-Benzyl-Oxopyrimidine (S-DABO) Derivatives as Potent HIV-1 Reverse Transcriptase Inhibitors with High Activity Against Clinically Relevant Mutants
Marco Radi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
1,2,3-thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors
Peng Zhan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
5-alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones, a series of anti-HIV-1 agents of the dihydro-alkoxy-benzyl-oxopyrimidine family with peculiar structure-activity relationship profile
Maxim B. Nawrozkij et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later
Christophe Pannecouque et al.
NATURE PROTOCOLS (2008)
Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase:: Synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants
Claudia Mugnaini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thiol-6(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series
YP He et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)